1763 — China Isotope & Radiation Share Price
0.000.00%
Last trade - 00:00- HK$3.68bn
- HK$6.54bn
- CNY7.57bn
- 33
- 76
- 88
- 76
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.69 | ||
| Price to Tang. Book | 0.75 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.46 | ||
| EV to EBITDA | 4.66 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.35% | ||
| Return on Equity | 8.39% | ||
| Operating Margin | 14.6% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 4,274.18 | 5,143.69 | 6,153.55 | 6,634.99 | 7,574.76 | n/a | n/a | 13.68% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -34.63 | +52.68 | +12.64 | -42.43 | +75.13 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Directors
- Yanbin Meng CHM (52)
- Liulai Zhou NVC (56)
- Laishui Wu CAO (45)
- Suohui Wang GMG (46)
- Guomin Fan DGM (48)
- Jin Du EDR (55)
- Jian Wu EDR (56)
- Youquan Gui SEC (46)
- Mei Ha Kam SEC (53)
- Jinyu Chang NED
- Shoulei Chen NED
- Qingliang Guo NID (63)
- Wan Fai Hui NID (45)
- Yan Meng NID (65)
- Jiahe Tian NID
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 31st, 1983
- Public Since
- July 6th, 2018
- No. of Employees
- 3,367
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 319,874,900
- Address
- No. 66 Changwa Middle Street, BEIJING
- Web
- http://www.china-isotope.com/
- Phone
- +86 1068411265
- Auditors
- SHINEWING (HK) CPA LIMITED
Upcoming Events for 1763
Similar to 1763
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the China Isotope & Radiation share price?
As of Today at 19:57 UTC, shares in China Isotope & Radiation are trading at HK$11.52. This share price information is delayed by 15 minutes.
How has the China Isotope & Radiation share price performed this year?
Shares in China Isotope & Radiation last closed at HK$11.52 and the price had moved by +12.06% over the past 365 days. In terms of relative price strength the China Isotope & Radiation share price has outperformed the FTSE Developed Asia Pacific Index by +13.34% over the past year.
What are the analyst and broker recommendations for China Isotope & Radiation?
The overall consensus recommendation for China Isotope & Radiation is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the China Isotope & Radiation dividend yield?
The China Isotope & Radiation dividend yield is 0.69% based on the trailing twelve month period.
Does China Isotope & Radiation pay a dividend?
Last year, China Isotope & Radiation paid a total dividend of CNY0.08, and it currently has a trailing dividend yield of 0.69%.Looking ahead, shares in China Isotope & Radiation are due to go ex-dividend on 2025-06-05 and the next dividend pay date is 2025-08-01.
When does China Isotope & Radiation next pay dividends?
China Isotope & Radiation are due to go ex-dividend on 2025-06-05 and the next dividend pay date is 2025-08-01. The historic dividend yield on China Isotope & Radiation shares is currently 0.69%.
How do I buy China Isotope & Radiation shares?
To buy shares in China Isotope & Radiation you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of China Isotope & Radiation?
As of the previous close price of HK$11.52, shares in China Isotope & Radiation had a market capitalisation of HK$3.68bn.
Where are China Isotope & Radiation shares listed?
Here are the trading details for China Isotope & Radiation:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1763
What kind of share is China Isotope & Radiation?
Based on an overall assessment of its quality, value and momentum China Isotope & Radiation is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a China Isotope & Radiation share price forecast for 2025?
The analyst consensus target price for shares in China Isotope & Radiation is HK$29.04. That is 152.1% above the last closing price of HK$11.52.
Analysts covering China Isotope & Radiation currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the China Isotope & Radiation share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like China Isotope & Radiation. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +10.57%.
As of the last closing price of HK$11.52, shares in China Isotope & Radiation were trading +5.12% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the China Isotope & Radiation PE Ratio?
The China Isotope & Radiation PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$11.52.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of China Isotope & Radiation?
China Isotope & Radiation's management team is headed by:
- Yanbin Meng - CHM
- Liulai Zhou - NVC
- Laishui Wu - CAO
- Suohui Wang - GMG
- Guomin Fan - DGM
- Jin Du - EDR
- Jian Wu - EDR
- Youquan Gui - SEC
- Mei Ha Kam - SEC
- Jinyu Chang - NED
- Shoulei Chen - NED
- Qingliang Guo - NID
- Wan Fai Hui - NID
- Yan Meng - NID
- Jiahe Tian - NID